ImmuniCell (autologous γδ T lymphocytes) / TC Biopharm  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ImmuniCell (autologous γδ T lymphocytes) / TC Biopharm
NCT02459067 / 2015-000402-19: ImmuniCell® in Patients With Advanced Cancers

Terminated
2
8
Europe
ImmuniCell®
TC Biopharm
Malignant Melanoma, Non-small Cell Lung Cancer, Renal Cell Cancer
11/18
11/18

Download Options